Xenotransplantation - Nuffield Council on Bioethics
Xenotransplantation - Nuffield Council on Bioethics
Xenotransplantation - Nuffield Council on Bioethics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Transmissi<strong>on</strong> of infectious diseases<br />
6.22 An implicati<strong>on</strong> of the principle of precauti<strong>on</strong> is that the development of some<br />
technologies simply should not be pursued. Since any innovati<strong>on</strong> must by definiti<strong>on</strong><br />
carry some unknowable risks, however, it would be unacceptably c<strong>on</strong>servative to<br />
restrict innovati<strong>on</strong> merely by appeal to the possibility of risk. For each technology,<br />
an attempt must be made to identify and define the risks and to decide <strong>on</strong> a course<br />
of acti<strong>on</strong>. It may be that, for some technologies, the principle of precauti<strong>on</strong> would<br />
argue that they should not be pursued. For others, it will be possible to identify<br />
safeguards that will reduce the risks of the technology.<br />
6.23 What are the implicati<strong>on</strong>s of the principle of precauti<strong>on</strong> when applied to the<br />
uncertainties associated with disease transmissi<strong>on</strong> via xenotransplantati<strong>on</strong>? The<br />
discussi<strong>on</strong> above has set out the potential risk from infectious organisms of animals<br />
and highlighted the difficulties in identifying these organisms, determining whether<br />
they will cause disease in human beings and predicting whether the diseases will<br />
spread to the wider populati<strong>on</strong>. The Working Party c<strong>on</strong>cluded that the risks<br />
associated with possible transmissi<strong>on</strong> of infectious diseases as a c<strong>on</strong>sequence<br />
of xenotransplantati<strong>on</strong> have not been adequately dealt with. It would not be<br />
ethical, therefore to begin clinical trials of xenotransplantati<strong>on</strong> involving<br />
human beings. In order to address the risks of disease transmissi<strong>on</strong> associated with<br />
xenotransplantati<strong>on</strong>, the Working Party suggests that the following measures should<br />
be taken:<br />
<br />
<br />
<br />
<br />
stringent efforts should be made to assemble as much informati<strong>on</strong> as possible<br />
about the risks of disease transmissi<strong>on</strong> before further xenotransplantati<strong>on</strong><br />
goes ahead. This would involve reviewing existing research and undertaking<br />
new research where necessary <strong>on</strong> the infectious organisms of primates and<br />
pigs and the possibility of transmissi<strong>on</strong> of disease to human beings<br />
(paragraphs 6.24 - 6.26);<br />
xenotransplantati<strong>on</strong> should use <strong>on</strong>ly source animals reared in c<strong>on</strong>diti<strong>on</strong>s in<br />
which all known infectious organisms are m<strong>on</strong>itored and c<strong>on</strong>trolled. It is<br />
ethically unacceptable to use source organs from animals that are known to<br />
be infected with infectious organisms that can be eliminated (paragraphs 6.27 -<br />
6.32);<br />
there should be thorough m<strong>on</strong>itoring of early recipients, with regular testing<br />
for signs and symptoms of disease (paragraphs 6.33 - 6.37);<br />
there should be a commitment to suspend, modify or, if necessary,<br />
disc<strong>on</strong>tinue xenotransplantati<strong>on</strong> procedures at any signs that new infectious<br />
diseases are emerging.<br />
The next secti<strong>on</strong>s discuss these requirements in more detail.<br />
75